In recent years, Robert Ripley has watched spiking drug prices menace his budget like a fast-rising flood.
The longtime chief of pharmacy for Trinity Health, a Catholic chain of 93 hospitals from New York to California, said he’s never seen anything like it in his 30-plus years in the business. The eye-popping prices of new branded drugs are one issue. But even worse are the wild price hikes and sudden shortages of generics that have been available for many decades.
“We’re paying more for drugs, and sometimes can’t get drugs, that our patients need,” Ripley said. “So we’re going to roll up our sleeves and do what we need to do.”
About the Author Reprints
Yeah, I already subscribe to the Globe, and this is an article in today’s paper. Why should I have to pay again to access it?
Bad Idea. Subscription within a subscription.
Congress should pass a law requiring any drug producer that received federal money for research to charge no more in the U S than the lowest price they charge outside the U S.
My insurance company is making me discontinue a drug, Gabapentin, Horizant to Gabapentin, Gralise due to price. The new drug didn’t work as well as the old one also.